ABEO
Price
$4.21
Change
-$0.28 (-6.25%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
242.78M
124 days until earnings call
Intraday BUY SELL Signals
ELVN
Price
$22.10
Change
-$0.49 (-2.17%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.31B
113 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABEO vs ELVN

Header iconABEO vs ELVN Comparison
Open Charts ABEO vs ELVNBanner chart's image
Abeona Therapeutics
Price$4.21
Change-$0.28 (-6.25%)
Volume$36.21K
Capitalization242.78M
Enliven Therapeutics
Price$22.10
Change-$0.49 (-2.17%)
Volume$7.68K
Capitalization1.31B
ABEO vs ELVN Comparison Chart in %
ABEO
Daily Signal:
Gain/Loss:
ELVN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ABEO vs. ELVN commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABEO is a Hold and ELVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ABEO: $4.48 vs. ELVN: $22.61)
Brand notoriety: ABEO and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABEO: 86% vs. ELVN: 114%
Market capitalization -- ABEO: $227.87M vs. ELVN: $1.31B
ABEO [@Biotechnology] is valued at $227.87M. ELVN’s [@Biotechnology] market capitalization is $1.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABEO’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 1 green FA rating(s).

  • ABEO’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 1 green, 4 red.
According to our system of comparison, ELVN is a better buy in the long-term than ABEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABEO’s TA Score shows that 5 TA indicator(s) are bullish while ELVN’s TA Score has 6 bullish TA indicator(s).

  • ABEO’s TA Score: 5 bullish, 4 bearish.
  • ELVN’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, ABEO is a better buy in the short-term than ELVN.

Price Growth

ABEO (@Biotechnology) experienced а +7.43% price change this week, while ELVN (@Biotechnology) price change was +15.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

ABEO is expected to report earnings on Mar 23, 2026.

ELVN is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.31B) has a higher market cap than ABEO($243M). ELVN YTD gains are higher at: 0.489 vs. ABEO (-19.569). ABEO has higher annual earnings (EBITDA): 80M vs. ELVN (-113.93M). ELVN has more cash in the bank: 491M vs. ABEO (226M). ELVN has less debt than ABEO: ELVN (580K) vs ABEO (24.1M). ABEO has higher revenues than ELVN: ABEO (400K) vs ELVN (0).
ABEOELVNABEO / ELVN
Capitalization243M1.31B19%
EBITDA80M-113.93M-70%
Gain YTD-19.5690.489-4,003%
P/E Ratio3.73N/A-
Revenue400K0-
Total Cash226M491M46%
Total Debt24.1M580K4,155%
FUNDAMENTALS RATINGS
ABEO: Fundamental Ratings
ABEO
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
20
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABEOELVN
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ABEO
Daily Signal:
Gain/Loss:
ELVN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
INUTX40.960.08
+0.20%
Columbia Dividend Opportunity A
PSCRX14.740.02
+0.14%
Putnam Small Cap Value R
KDHIX52.51N/A
N/A
DWS CROCI Equity Dividend Inst
FCAEX14.36N/A
N/A
Fidelity Climate Action
CBLAX56.31-0.33
-0.58%
Columbia Balanced A

ABEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABEO has been loosely correlated with OCUL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ABEO jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
-0.67%
OCUL - ABEO
47%
Loosely correlated
-1.09%
IPSC - ABEO
45%
Loosely correlated
+1.99%
ELVN - ABEO
44%
Loosely correlated
+3.91%
RGNX - ABEO
44%
Loosely correlated
+0.94%
AURA - ABEO
44%
Loosely correlated
-1.64%
More